Krystal Biotech Other Long Term Liabilities (Quarterly) Analysis

Krystal Biotech, Inc. (KRYS)

267.11 -7.48 (-2.72%) USD | NASDAQ | Feb 24, 14:12

View Other Long Term Liabilities (Quarterly) for KRYS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	Upgrade
DexCom, Inc.	Upgrade
Alkermes Plc	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade